高性能醫(yī)用鈷基合金強化機理的研究進展
發(fā)布人：上海艾荔艾合金股份有限公司www.shailiai.cn
更新時間：2016-06-03
MP35N合金是一種高性能醫(yī)用鈷基合金，具有優(yōu)良力學性能、耐腐蝕和良好的生物相容性等優(yōu)點，在醫(yī)療器械和航天航空具有廣闊的應用前景。綜述MP35N合金的力學性能和兩種強化工藝冷變形和時效處理對其性能的影響，將MP35N合金強化機理分為4類并加以詳細闡述，描述不同強化機理的發(fā)展歷程和現(xiàn)狀。分析MP35N合金不同強化機理的優(yōu)缺點和未來關于MP35N合金的研究思路。
高性能醫(yī)用鈷基合金強化機理的研究進展Progress on strengthening mechanisms of high performance medical cobalt based alloyMP35N合金是一種高性能醫(yī)用鈷基合金，具有優(yōu)良力學性能、耐腐蝕和良好的生物相容性等優(yōu)點，在醫(yī)療器械和航天航空具有廣闊的應用前景。綜述MP35N合金的力學性能和兩種強化工藝冷變形和時效處理對其性能的影響，將MP35N合金強化機理分為4類并加以詳細闡述，描述不同強化機理的發(fā)展歷程和現(xiàn)狀。分析MP35N合金不同強化機理的優(yōu)缺點和未來關于MP35N合金的研究思路。
MP35N alloy is a kind of high performance medical cobalt based alloy，which has good mechanical properties, corrosion resistance and good biocompatibility. It has wide application prospect in medical devices and aerospace. The mechanical properties of MP35N alloy and two kinds of strengthening processes on properties of the alloy were summarized. The strengthening mechanism of MP35N alloy was divided into four categories, and the development and current situation of different strengthening mechanisms were described. The advantages and disadvantages of different strengthening mechanisms of MP35N alloy as well as the ideas about MP35N alloy in the future research were analyzed.
作為值得信賴的合作伙伴和高品質(zhì)金屬合金的半成品供應商，艾荔艾擁有完善的服務體系和專業(yè)的團隊。在同客戶交易的過程中，我們力求根據(jù)不同的應用需求將我們的產(chǎn)品做到精益求精。針對當前和未來的市場需求，艾荔艾致力于為客戶提供最佳的金屬材料解決方案。
AILIAI
has been a reliable partner and supplier of sophisticated and high-quality
semi-finished products maed of alloys. In dialogue with our customers, we
optimise our products to meet the specific application requirements. AILIAI
develops the best alloy material solutions for current and future
challenges.
獲取更多我們供應的合金和服務信息，請致電086-021-67660801或發(fā)電子郵件[email protected]聯(lián)系我們，您也可以通過微博，微信，領英，XING，臉書和推特與我們互動。
For
more information on the alloys and services that we supply,?call
us?at
086-021-67660801 or email us at [email protected]. You can also get in touch
on social media, we are constantly active on?Weibo,?Weixin,?LinkedIn,?XING, Facebook?and?Twitter.